← Open Payments lookup

JACE HEBERT: Open Payments

NPI 1730533761 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$830 in 38 payments from 8 companies in 2025. Trend: 2023 $957 · 2024 $722 · 2025 $830

Food & beverage: $830
CompanyPaymentsAmount
Alkermes, Inc.16$264
Janssen Pharmaceuticals, Inc5$195
E.R. Squibb & Sons, L.L.C.8$156
Vanda Pharmaceuticals Inc.2$64
Otsuka America Pharmaceutical, Inc.3$59
Teva Pharmaceuticals USA, Inc.2$51
Luye Pharma (USA) Ltd.1$20
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$20

Products named: ARISTADA, INVEGA SUSTENNA, COBENFY, FANAPT, UZEDY, ABILIFY ASIMTUFII, ERZOFRI EXTENDED-RELEASE, CAPLYTA.

Industry payments across LA — which companies pay providers there.